Cannabis Law Report

MARCH 29, 2022

Rebuilt in 2008, Greenfern’s crowdfunding campaign in 2020 enabled the firm to buy the power station outright. While its research, indoor growing operation and processing facility may be right next to a river offering plenty of water, the aeroponics system Greenfern Industries use reduces its water consumption too.

Clinical Trials 52

Clinical Trials Medicine Environment Consumption 52

CannaMD

AUGUST 26, 2020

Most studies were published in the last five years, while the rest were published between 1994 and 2008. Note: No human studies were found (with the exception of one clinical trial that was ongoing and therefore not selected); all studies focused on animals (i.e., mice/rats). Conclusion?

Therapy 98

Therapy CBD Research and Development Treatment 98

The Cannigma

JANUARY 13, 2023

Treating migraine pain is one of the instances where inhaled cannabis consumption, such as smoking or vaping , is important for the right effects and speed of delivery. 1 A 2008 study found serotonin and endocannabinoid levels, including anandamide, were lower in people with chronic migraines. headaches per month.

Terpenes 132

Terpenes Strains THC Treatment 132

Cannabis Law Report

NOVEMBER 24, 2021

2018 ; Frankhauser 2008 ). 2008 )—were difficult for any plant to compete with, especially one whose active constituents would not be revealed for another 30?years It is unclear whether doctors are feeling completely reassured by laboratory and clinical trial research into medicinal cannabis. 2016 ; Sznitman et al.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

OCTOBER 29, 2019

Wakshlag is well-known in the veterinary medicine community as the first doctor to conduct an efficacy study in dogs in a clinical trial at Cornell using ElleVet CBD/CBDA on dogs with multi-joint discomfort. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.

Safety 45

Safety CBD Clinical Trials Oil 45

Cannabis Law Report

JULY 12, 2019

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. W-SV Ho1, DA Barrett2 and MD Randall1.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73